Limitation on Future Financing. From the date hereof until the earlier of 120 calendar days after the Closing Date or 15 calendar days after the Effective Date, the Company shall not effect a financing of its Common Stock or Common Stock Equivalents (a "Subsequent Financing"). Further, the Company shall not file any registration statement with respect to any Subsequent Financing prior to 15 calendar days after the Effective Date. Notwithstanding anything to the contrary herein, this Section 4.4 shall not apply to the following: (a) the granting of options to employees, officers and directors of the Company pursuant to any stock option plan duly adopted by a majority of the non-employee members of the Board of Directors of the Company or a majority of the members of a committee of non-employee directors established for such purpose (and the exercise of such options), or (b) the exercise of any security issued by the Company in connection with the offer and sale of the Company's securities pursuant to this Agreement, or (c) the exercise of or conversion of any convertible securities, options or warrants issued and outstanding on the date hereof, provided such securities have not been amended since the date hereof, or (d) acquisitions or strategic investments, the primary purpose of which is not to raise capital.
Appears in 4 contracts
Samples: Securities Purchase Agreement (Vion Pharmaceuticals Inc), Securities Purchase Agreement (Vion Pharmaceuticals Inc), Securities Purchase Agreement (Scolr Inc)